Send to

Choose Destination
See comment in PubMed Commons below
Mt Sinai J Med. 2005 Jul;72(4):250-6.

Monoclonal antibodies, immunogenicity, and associated infusion reactions.

Author information

Division of Gastroenterology, Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029, USA.


The increasing use of monoclonal antibodies as treatment modalities for a number of immune mediated and malignant diseases has yielded great promise. In using this approach, however, we have encountered problems, in terms of infusion reactions. Two forms of reactions have been identified: acute and delayed; they appear to be related to the presence of antibodies to the monoclonal antibodies (against murine or human components). The reactions are largely not anaphylactic (IgE mediated), making it possible to re-treat patients using specific protocols. These protocols are detailed in this overview.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center